After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Entero Therapeutics Inc. is $2.36M. A total of 1.17 million shares were traded on the day, compared to an average of 782.39K shares.
In the most recent transaction, Romano Sarah sold 476 shares of ENTO for 0.45 per share on Oct 09 ’24. After the transaction, the Chief Financial Officer now owns 18,014 company shares. In a previous transaction on Jul 02 ’24, Romano Sarah sold 621 shares at 1.07 per share. ENTO shares that Chief Financial Officer owns now total 18,490.
Among the insiders who sold shares, SAPIRSTEIN JAMES disposed of 1,289 shares on Jul 02 ’24 at a per-share price of $1.07. This resulted in the Chairman and CEO holding 35,816 shares of ENTO after the transaction. In another insider transaction, SAPIRSTEIN JAMES sold 174 shares at $4.23 per share on Apr 01 ’24. Company shares held by the Chairman and CEO now total 37,105.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, ENTO has a high of $14.51 and a low of $0.19.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. ENTO’s latest balance sheet shows that the firm has $8.25M in Cash & Short Term Investments as of fiscal 2021. There were $1.03M in debt and $12.30M in liabilities at the time. Its Book Value Per Share was $7.99, while its Total Shareholder’s Equity was -$7.82M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ENTO is Buy with a score of 5.00.
